Live Oak Health Sciences Fund
Filed by Oak Associates Funds. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| CAHCardinal Health Inc | 5.86% | $3.3M |
| UTHRUnited Therapeutics Corp | 5.11% | $2.9M |
| EXELExelixis Inc | 4.95% | $2.8M |
| AMGNAmgen Inc | 4.86% | $2.7M |
| LNTHLantheus Holdings Inc | 4.68% | $2.6M |
| NVSNovartis AG | 4.67% | $2.6M |
| MCKMcKesson Corp | 4.53% | $2.5M |
| CORCencora Inc | 4.46% | $2.5M |
| REGNRegeneron Pharmaceuticals Inc | 4.43% | $2.5M |
| BMYBristol-Myers Squibb Co | 4.02% | $2.3M |
| JNJJohnson & Johnson | 3.77% | $2.1M |
| MEDPMedpace Holdings Inc | 3.69% | $2.1M |
| GILDGilead Sciences, Inc | 3.50% | $2M |
| CICigna Group | 3.46% | $1.9M |
| INCYIncyte Corp | 3.30% | $1.9M |
| VRTXVertex Pharmaceuticals Inc | 3.26% | $1.8M |
| MRKMerck & Co Inc | 3.16% | $1.8M |
| ISRGIntuitive Surgical Inc | 2.99% | $1.7M |
| NVONovo Nordisk A/S | 2.51% | $1.4M |
| LHLabcorp Holdings Inc | 2.29% | $1.3M |
| LLYEli Lilly and Co | 1.99% | $1.1M |
| SYKStryker Corp | 1.97% | $1.1M |
| ELVElevance Health Inc | 1.09% | $609.2K |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Live Oak Health Sciences Fund by email
Live Oak Health Sciences Fund's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.